1Flynn CG. A review of continuous renal replacement therapy. Ir J Med Sci, 1994, 163(7):331-340
2Van Bommel EF. Renal replacement therapy for acute renal failure on the intensive care unit: coming of age? Neth J Med, 2003, 61(8):239-248
3Schetz M, Leblanc M, Murray PT. The Acute Dialysis Quality Initiative -part Ⅶ:fluid composition and management in CRRT. Adv Ren Replace Ther, 2002, 9(4):282-289
4Davenport A. Dialysate and substitution fluids for patients treated by continuous forms of renal replacement therapy. Contrib Nephrol, 2001,(132):313 - 322
5Van den Berghe. Insulin therapy for the critically ill patient.Clin Cornerstone, 2003,5(2) :56 - 63
6Fortin MC, Amyot SL, Gendah D, et al. Scrum concentrations and clearances of folio acid and pyridoxal - 5 - phosphate during venovenous continuous renal replacement therapy. Intensive Care Med, 1999, 25(6):594- 8
2Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000[J]. N Engl J Med,2003,348(16) :1546-1554.
3杨霁云,白克敏.小儿肾脏病基础与临床[M].北京:人民卫生出版社,2004:450-455.
4Bellomo R, Tippint P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients[J]. Crit Care Med, 1993,21(4): 522-526.
5Ronco C, Brendolan A, Milan M, et al. Impact of biofeedback- induced cardiovascular stability on hemodialysis tolerance and efficiency[J]. Kidney Int,2000,58(2) :800-808.
6Su X,Bai C, Hong Q, et al. Effect of continuous hemofiltration on hemodynamics,lung inflammation and pulmonary edema in a canine model of acute lung injury[J]. Intensive Care Med, 2003, 29(11) :2034-2042.
